|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication May 2, 2006.
Revised August 14, 2006.
Accepted for publication September 8, 2006.
2,3-butanedione monoxime (BDM) is widely believed to act as a chemical phosphatase. We
therefore examined BDM's effects on the cystic fibrosis transmembrane conductance regulator
(CFTR) Cl- channel, which is regulated by phosphorylation in a complex manner. In guinea pig
ventricular myocytes, forskolin-activated whole-cell CFTR currents responded biphasically to
external 20 mM BDM: a rapid ~2-fold current activation was followed by a slower (
~20 s)
inhibition (to ~20 % of control). The inhibitory response was abolished by intracellular dialysis
with the phosphatase inhibitor microcystin, suggesting involvement of endogenous phosphatases.
The BDM-induced activation was studied further in Xenopus oocytes expressing human
epithelial CFTR. The concentration for half-maximal BDM activation (K0.5) was statedependent,
~2 mM for highly and ~20 mM for partially phosphorylated channels, suggesting a
modulated receptor mechanism. Because BDM modulates many different membrane proteins
with similar K0.5s, we tested whether BDM could alter protein function by altering lipid bilayer
properties rather than by direct BDM-protein interactions. Using gramicidin channels of
different lengths (different channel-bilayer hydrophobic mismatch) as reporters of bilayer
stiffness, we found that BDM increases channel appearance rates and lifetimes (reduces bilayer
stiffness). At 20 mM BDM, the appearance rates increase ~4 fold (for the longer, 15
residues/monomer, channels) to ~10 fold (for the shorter, 13 residues/monomer, channels); the
lifetimes increase ~50% independent of channel length. BDM thus reduces the energetic cost of
bilayer deformation, an effect that may underlie BDM's effects on CFTR and other membrane
proteins; the state-dependent changes in K0.5 are consistent with such a bilayer-mediated
mechanism.
Key words:
Ion channel regulation, Ion transporters (SERCA, Na/K ATPase, CFTR)